← All Sponsors

SPONSOR

Asger Sverrild

Total Trials

1

Recruiting

1

Phases

Phase 2

Conditions studied: COPD COPD Exacerbation COPD Bronchitis Airway Disease Immune System Disorder

NCT05507242 Phase 2

Effects of Blocking TSLP on Airway Inflammation and the Epithelial Immune-response to Exacerbation Triggers in Patients With COPD